<i>In silico</i> exploration of venlafaxine, a potential non-tricyclic antidepressant in a liposomal formulation for nose-to-brain drug delivery-Reference-Cited by-同舟云学术

In silico exploration of venlafaxine, a potential non-tricyclic antidepressant in a liposomal formulation for nose-to-brain drug delivery

Published:2023-12-25 Issue:1 Volume:50 Page:55-67
ISSN:0363-9045
Container-title:Drug Development and Industrial Pharmacy
language:en
Short-container-title:Drug Development and Industrial Pharmacy

Author:

Khute Sulekha¹^ORCID,Jangde Rajendra K.¹

Affiliation:

1. University Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, Chhattisgarh, India

Publisher

Informa UK Limited

Subject

Organic Chemistry,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.tandfonline.com/doi/pdf/10.1080/03639045.2023.2297238

Reference54 articles.

1. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care

2. Bains N, Abdijadid S. Major depressive disorder. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2022; PMID: 32644504.

3. SNRIs versus SSRIs: mechanisms of action in treating depression and painful physical symptoms;Sussman N.;Prim Care Companion J Clin Psychiatry,2003

4. Nontricyclic Antidepressants: Current Trends in Children and Adolescents

5. Antidepressant and anti-suicidal effects of ketamine in treatment-resistant depression associated with psychiatric and personality comorbidities: A double-blind randomized trial

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advanced drug delivery technologies for postmenopausal effects;Journal of Controlled Release;2024-09

2. Emerging Trends in Hybrid Nanoparticles: Revolutionary Advances and Promising Biomedical Applications;Current Drug Metabolism;2024-05